1. Home
  2. RPID vs ELUT Comparison

RPID vs ELUT Comparison

Compare RPID & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rapid Micro Biosystems Inc.

RPID

Rapid Micro Biosystems Inc.

SELL

Current Price

$0.74

Market Cap

34.7M

Sector

Health Care

ML Signal

SELL

Logo Elutia Inc.

ELUT

Elutia Inc.

SELL

Current Price

$0.83

Market Cap

35.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
RPID
ELUT
Founded
2006
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.7M
35.6M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
RPID
ELUT
Price
$0.74
$0.83
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
★ $6.00
N/A
AVG Volume (30 Days)
★ 151.4K
70.2K
Earning Date
11-27-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
2.78
★ 146.77
EPS
N/A
★ N/A
Revenue
★ $33,587,000.00
$12,293,000.00
Revenue This Year
$16.95
N/A
Revenue Next Year
$17.92
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 19.74
N/A
52 Week Low
$0.58
$0.50
52 Week High
$4.94
$1.39

Technical Indicators

Market Signals
Indicator
RPID
ELUT
Relative Strength Index (RSI) 44.29 47.95
Support Level $0.58 $0.73
Resistance Level $2.18 $0.87
Average True Range (ATR) 0.07 0.07
MACD 0.01 0.00
Stochastic Oscillator 66.24 43.48

Price Performance

Historical Comparison
RPID
ELUT

About RPID Rapid Micro Biosystems Inc.

Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.

About ELUT Elutia Inc.

Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.

Share on Social Networks: